307 related articles for article (PubMed ID: 36675832)
1. Non-
Gómez-Gaviria M; Ramírez-Sotelo U; Mora-Montes HM
J Fungi (Basel); 2022 Dec; 9(1):. PubMed ID: 36675832
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and Antifungal Susceptibility of
Badiee P; Boekhout T; Haddadi P; Mohammadi R; Ghadimi-Moghadam A; Soltani J; Zarei Mahmoudabadi A; Ayatollahi Mousavi SA; Najafzadeh MJ; Diba K; Salimi-Khorashad AR; Amin Shahidi M; Ghasemi F; Jafarian H
Microbiol Spectr; 2022 Dec; 10(6):e0245322. PubMed ID: 36445122
[TBL] [Abstract][Full Text] [Related]
5. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
6. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
8. Candida auris Cell Wall Mannosylation Contributes to Neutrophil Evasion through Pathways Divergent from Candida albicans and Candida glabrata.
Horton MV; Johnson CJ; Zarnowski R; Andes BD; Schoen TJ; Kernien JF; Lowman D; Kruppa MD; Ma Z; Williams DL; Huttenlocher A; Nett JE
mSphere; 2021 Jun; 6(3):e0040621. PubMed ID: 34160238
[TBL] [Abstract][Full Text] [Related]
9. Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database.
Colombo AL; Ngai AL; Bourque M; Bradshaw SK; Strohmaier KM; Taylor AF; Lupinacci RJ; Kartsonis NA
Antimicrob Agents Chemother; 2010 May; 54(5):1864-71. PubMed ID: 20231388
[TBL] [Abstract][Full Text] [Related]
10.
Gómez-Gaviria M; Martínez-Álvarez JA; Chávez-Santiago JO; Mora-Montes HM
Infect Drug Resist; 2023; 16():1455-1470. PubMed ID: 36942024
[TBL] [Abstract][Full Text] [Related]
11. Antifungal and anti-biofilm effect of the calcium channel blocker verapamil on non-albicans Candida species.
Scorzoni L; Menezes RT; Pereira TC; Oliveira PS; Ribeiro FC; Santos ELS; Fugisaki LRO; Oliveira LD; Amorim JBO
An Acad Bras Cienc; 2020; 92(4):e20200703. PubMed ID: 33331390
[TBL] [Abstract][Full Text] [Related]
12. Candida glabrata - basic characteristics, virulence, treatment, and resistance.
Eliaš D; Gbelská Y
Epidemiol Mikrobiol Imunol; 2022; 71(2):118-134. PubMed ID: 35940866
[TBL] [Abstract][Full Text] [Related]
13. Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90.
Matthews RC; Rigg G; Hodgetts S; Carter T; Chapman C; Gregory C; Illidge C; Burnie J
Antimicrob Agents Chemother; 2003 Jul; 47(7):2208-16. PubMed ID: 12821470
[TBL] [Abstract][Full Text] [Related]
14. Distribution and antifungal susceptibility pattern of
Bilal H; Shafiq M; Hou B; Islam R; Khan MN; Khan RU; Zeng Y
Virulence; 2022 Dec; 13(1):1573-1589. PubMed ID: 36120738
[TBL] [Abstract][Full Text] [Related]
15. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
[TBL] [Abstract][Full Text] [Related]
16. Candida glabrata among Candida spp. from environmental health practitioners of a Brazilian Hospital.
Savastano C; de Oliveira Silva E; Gonçalves LL; Nery JM; Silva NC; Dias AL
Braz J Microbiol; 2016; 47(2):367-72. PubMed ID: 26991302
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Pathogenic
Singh DK; Tóth R; Gácser A
Front Cell Infect Microbiol; 2020; 10():94. PubMed ID: 32232011
[No Abstract] [Full Text] [Related]
18. Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study.
Mokaddas EM; Al-Sweih NA; Khan ZU
J Med Microbiol; 2007 Feb; 56(Pt 2):255-259. PubMed ID: 17244809
[TBL] [Abstract][Full Text] [Related]
19. Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in
Espinel-Ingroff A; Turnidge J; Alastruey-Izquierdo A; Botterel F; Canton E; Castro C; Chen YC; Chen Y; Chryssanthou E; Dannaoui E; Garcia-Effron G; Gonzalez GM; Govender NP; Guinea J; Kidd S; Lackner M; Lass-Flörl C; Linares-Sicilia MJ; López-Soria L; Magobo R; Pelaez T; Quindós G; Rodriguez-Iglesia MA; Ruiz MA; Sánchez-Reus F; Sanguinetti M; Shields R; Szweda P; Tortorano A; Wengenack NL; Bramati S; Cavanna C; DeLuca C; Gelmi M; Grancini A; Lombardi G; Meletiadis J; Negri CE; Passera M; Peman J; Prigitano A; Sala E; Tejada M
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323038
[TBL] [Abstract][Full Text] [Related]
20. A retrospective analysis of antifungal susceptibilities of Candida bloodstream isolates from Singapore hospitals.
Tan TY; Tan AL; Tee NW; Ng LS
Ann Acad Med Singap; 2008 Oct; 37(10):835-40. PubMed ID: 19037517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
